Liraglutide promotes the angiogenic ability of human umbilical vein endothelial cells through the JAK2/STAT3 signaling pathway

Di, YB; He, J; Ma, P; Shen, N; Niu, CH; Liu, X; Du, XM; Tian, FS; Li, HM; Liu, Y

Li, HM; Liu, Y (corresponding author), Tianjin Med Univ, Nankai Univ, Ctr Clin Coll 4, Cent Hosp 4,Tianjin Ctr Hosp 4,Dept Cardiol, 1 Zhongshan Rd, Tianjin 300140, Peoples R China.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020; 523 (3): 666

Abstract

Liraglutide is a glucagon-like peptide-1 receptor (GLP-1R) agonist and incretin mimetic used for the treatment of Type 2 diabetes mellitus. It has als......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索